Article/Poster

2025.07.17

Academic Paper on eNK Cells in “Stem Cell Research and Therapy” Human iPSC-derived NK cells armed with CCL19, CCR2B, high-affinity CD16, IL-15, and NKG2D complex enhance anti-solid tumor activity

researchers at Healios have published a recent work revealing the anti-tumor activity of human iPSC-derived NK cells (Healios eNK cells) expressing CCL19, CCR2B, high-affinity CD16, IL-15, and NKG2D complexes by gene editing on solid tumors. This work has been published in the peer-reviewed journal “Stem Cell Research & Therapy”.

 

Title: Human iPSC‑derived NK cells armed with CCL19, CCR2B, high‑affinity CD16, IL‑15, and NKG2D complex enhance anti‑solid tumor activity